NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Reaches New 12-Month High – Time to Buy?

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as C$5.77 and last traded at C$5.74, with a volume of 262359 shares. The stock had previously closed at C$5.72.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Royal Bank Of Canada set a C$5.50 target price on NorthWest Health Prop Real Est Inv Trust and gave the company a “sector perform” rating in a research note on Monday, November 24th. CIBC upped their price objective on shares of NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.75 in a report on Thursday, November 13th. Scotiabank lifted their target price on shares of NorthWest Health Prop Real Est Inv Trust from C$6.50 to C$7.00 in a research note on Thursday, November 13th. Finally, BMO Capital Markets increased their price target on shares of NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$6.00 in a research note on Thursday, November 13th. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of C$6.00.

NorthWest Health Prop Real Est Inv Trust Trading Down 1.4%

The company has a 50 day moving average of C$5.38 and a two-hundred day moving average of C$5.16. The stock has a market capitalization of C$1.42 billion, a PE ratio of 28.30, a P/E/G ratio of 0.74 and a beta of 1.78. The company has a debt-to-equity ratio of 129.42, a quick ratio of 0.06 and a current ratio of 0.25.

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) last issued its quarterly earnings results on Tuesday, November 11th. The company reported C$0.06 earnings per share for the quarter. NorthWest Health Prop Real Est Inv Trust had a negative return on equity of 14.67% and a negative net margin of 75.29%.The business had revenue of C$110.69 million during the quarter. Sell-side analysts predict that NorthWest Health Prop Real Est Inv Trust will post 0.4905498 EPS for the current year.

About NorthWest Health Prop Real Est Inv Trust

Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.